About this Journal Submit a Manuscript Table of Contents
Advances in Pharmacological Sciences
Volume 2011 (2011), Article ID 326724, 6 pages
http://dx.doi.org/10.1155/2011/326724
Review Article

Toxicokinetics of Kava

Faculty of Pharmacy, University of Sydney, Bank Building (A15), Sydney, NSW 2006, Australia

Received 30 November 2010; Accepted 24 January 2011

Academic Editor: Charles P. France

Copyright © 2011 Anthony Rowe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. Whitton, A. Lau, A. Salisbury, J. Whitehouse, and C. S. Evans, “Kava lactones and the kava-kava controversy,” Phytochemistry, vol. 64, no. 3, pp. 673–679, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. P. P. Fu, Q. Xia, L. Guo, H. Yu, and P. C. Chan, “Toxicity of kava kava,” Journal of Environmental Science and Health, Part C, vol. 26, no. 1, pp. 89–112, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. R. Teschke, J. Sarris, and V. Lebot, “Kava hepatotoxicity solution: a six-point plan for new kava standardization,” Phytomedicine, vol. 18, no. 2-3, pp. 96–103, 2011. View at Publisher · View at Google Scholar · View at PubMed
  4. L. D. Dinh, U. Simmen, K. B. Bueter, B. Bueter, K. Lundstrom, and W. Schaffner, “Interaction of various Piper methysticum cultivars with CNS receptors in vitro,” Planta Medica, vol. 67, no. 4, pp. 306–311, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. N. P. Clayton, K. Yoshizawa, G. E. Kissling, L. T. Burka, P. C. Chan, and A. Nyska, “Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract,” Experimental and Toxicologic Pathology, vol. 58, no. 4, pp. 223–236, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. L. Zou, G. L. Henderson, M. R. Harkey, Y. Sakai, and A. Li, “Effects of kava (kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes,” Phytomedicine, vol. 11, no. 4, pp. 285–294, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. P. J. Mulholland and M. A. Prendergast, “Post-insult exposure to (±) kavain potentiates N-methyl-D-aspartate toxicity in the developing hippocampus,” Brain Research, vol. 945, no. 1, pp. 106–113, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Tang, R. A. Dunlop, A. Rowe, K. J. Rodgers, and I. Ramzan, “Kavalactones yangonin and methysticin induce apoptosis in human hepatocytes (HepG2) in vitro,” Phytotherapy Research, vol. 25, no. 3, pp. 417–423, 2011.
  9. F. Tarbah, Y. Barguil, W. Weinmann, et al., “Death after consumption of kava beverage in combination with alcohol and cannabis,” in GTFCh (Society of Toxicological and Forensic Chemistry) Symposium, Mosbach, Germany, 2003.
  10. K. Dragull, W. Y. Yoshida, and C. S. Tang, “Piperidine alkaloids from Piper methysticum,” Phytochemistry, vol. 63, no. 2, pp. 193–198, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. P. V. Nerurkar, K. Dragull, and C. S. Tang, “In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones,” Toxicological Sciences, vol. 79, no. 1, pp. 106–111, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. T. S. Lim, K. Dragull, C. S. Tang, H. C. Bittenbender, J. T. Efird, and P. V. Nerurkar, “Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats,” Toxicological Sciences, vol. 97, no. 1, pp. 214–221, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. Lechtenberg, B. Quandt, M. Schmidt, and A. Nahrstedt, “Is the alkaloid pipermethystine connected with the claimed liver toxicity of kava products?” Pharmazie, vol. 63, no. 1, pp. 71–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. W. Jhoo, J. P. Freeman, T. M. Heinze et al., “In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum),” Journal of Agricultural and Food Chemistry, vol. 54, no. 8, pp. 3157–3162, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. T. D. Xuan, M. Fukuta, A. C. Wei, A. A. Elzaawely, T. D. Khanh, and S. Tawata, “Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots,” Journal of Natural Medicines, vol. 62, no. 2, pp. 188–194, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. P. Zhou, S. Gross, J.-H. Liu et al., “Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-κB and MAPK signaling pathways,” FASEB Journal, vol. 24, no. 12, pp. 4722–4732, 2010. View at Publisher · View at Google Scholar · View at PubMed
  17. “Vanuatu Legislation: Kava Act,” 2002, http://www.paclii.org/databases.html#VU.
  18. V. Lebot, M. Merlin, and L. Lindstrom, Kava, the Pacific Elixir, Yale University Press, Rochester, Vt, USA, 1997.
  19. R. Teschke, A. Genthner, and A. Wolff, “Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures,” Journal of Ethnopharmacology, vol. 123, no. 3, pp. 378–384, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. H. Pittler and E. Ernst, “Kava extract for treating anxiety,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD003383, 2003. View at Scopus
  21. S. Witte, D. Loew, and W. Gaus, “Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders,” Phytotherapy Research, vol. 19, no. 3, pp. 183–188, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. K. M. Connor, J. R. T. Davidson, L. E. Churchill, S. Witte, D. Loew, and W. Gaus, “Adverse-effect profile of kava,” CNS Spectrums, vol. 6, no. 10, pp. 848–853, 2001. View at Scopus
  23. D. L. Clouatre, “Kava kava: examining new reports of toxicity,” Toxicology Letters, vol. 150, no. 1, pp. 85–96, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. R. Teschke, A. Schwarzenboeck, and K. H. Hennermann, “Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases,” European Journal of Gastroenterology & Hepatology, vol. 20, no. 12, pp. 1182–1193, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. Teschke, A. Schwarzenboeck, and A. Akinci, “Kava hepatotoxicity: a European view,” New Zealand Medical Journal, vol. 121, no. 1283, pp. 90–98, 2008. View at Scopus
  26. S. A. Norton and P. Ruze, “Kava dermopathy,” Journal of the American Academy of Dermatology, vol. 31, no. 1, pp. 89–97, 1994. View at Scopus
  27. C. Ulbricht, E. Basch, H. Boon et al., “Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration,” Expert Opinion on Drug Safety, vol. 4, no. 4, pp. 779–794, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. I. Ramzan and H. V. Tran, “Chemistry of kava and kavalactones,” in Kava: From Ethnology to Pharmacology (Medicinal and Aromatic Plants—Industrial Profile), Y. N. Singh, Ed., pp. 76–103, CRC Press, Boca Raton, Fla, USA, 2004.
  29. J. Barnes, L. A. Anderson, and J. D. Phillipson, “Herbal Medicines,” 2007, http://www.medicinescomplete.com/mc/herbals/2008/1000734502.htm#hrb1000756090.
  30. A. M. Duffield, D. D. Jamieson, R. O. Lidgard, P. H. Duffield, and D. J. Bourne, “Identification of some human urinary metabolites of the intoxicating beverage kava,” Journal of Chromatography A, vol. 475, pp. 273–281, 1989. View at Scopus
  31. C. Köppel and J. Tenczer, “Mass spectral characterization of urinary metabolites of D,L-kawan,” Journal of Chromatography B, vol. 562, no. 1-2, pp. 207–211, 1991. View at Publisher · View at Google Scholar · View at Scopus
  32. A. K. Rasmussen, R. R. Scheline, E. Solheim, and R. Hansel, “Metabolism of some kava pyrones in the rat,” Xenobiotica, vol. 9, no. 1, pp. 1–16, 1979. View at Scopus
  33. F. Tarbah, H. Mahler, B. Kardel, W. Weinmann, D. Hafner, and T. Daldrup, “Kinetics of kavain and its metabolites after oral application,” Journal of Chromatography B, vol. 789, no. 1, pp. 115–130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Zou, M. R. Harkey, and G. L. Henderson, “Synthesis, in vitro reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion,” Planta Medica, vol. 71, no. 2, pp. 142–146, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. B. M. Johnson, S. X. Qiu, S. Zhang et al., “Identification of novel electrophilic metabolites of Piper methysticum Forst. (kava),” Chemical Research in Toxicology, vol. 16, no. 6, pp. 733–740, 2003. View at Scopus
  36. J. M. Mathews, A. S. Etheridge, J. L. Valentine et al., “Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro,” Drug Metabolism and Disposition, vol. 33, no. 10, pp. 1555–1563, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. S. Russmann, Y. Barguil, P. Cabalion, M. Kritsanida, D. Duhet, and B. H. Lauterburg, “Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia,” European Journal of Gastroenterology & Hepatology, vol. 15, no. 9, pp. 1033–1036, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Russmann, B. H. Lauterburg, and A. Helbling, “Kava hepatotoxicity,” Annals of Internal Medicine, vol. 135, no. 1, pp. 68–69, 2001. View at Scopus
  39. M. Ingelman-Sundberg, “Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity,” Pharmacogenomics Journal, vol. 5, no. 1, pp. 6–13, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. Escher, J. Desmeules, E. Giostra, and G. Mentha, “Hepatitis associated with kava, a herbal remedy for anxiety,” British Medical Journal, vol. 322, no. 7279, p. 139, 2001. View at Scopus
  41. S. Fu, E. Korkmaz, F. Braet, Q. Ngo, and I. Ramzan, “Influence of kavain on hepatic ultrastructure,” World Journal of Gastroenterology, vol. 14, no. 4, pp. 541–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. A. R. Clough, S. P. Jacups, Z. Wang et al., “Health effects of kava use in an eastern Arnhem Land Aboriginal community,” Internal Medicine Journal, vol. 33, no. 8, pp. 336–340, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. A. R. Clough, R. S. Bailie, and B. Currie, “Liver function test abnormalities in users of aqueous kava extracts,” Journal of Toxicology. Clinical Toxicology, vol. 41, no. 6, pp. 821–829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. A. C. Brown, J. Onopa, P. Holck et al., “Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii,” Clinical Toxicology, vol. 45, no. 5, pp. 549–556, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. G. Zollner and M. Trauner, “Mechanisms of cholestasis,” Clinics in Liver Disease, vol. 12, no. 1, pp. 1–26, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. R. A. Roberts, P. E. Ganey, C. Ju, L. M. Kamendulis, I. Rusyn, and J. E. Klaunig, “Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis,” Toxicological Sciences, vol. 96, no. 1, pp. 2–15, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. G. Kolios, V. Valatas, and E. Kouroumalis, “Role of Kupffer cells in the pathogenesis of liver disease,” World Journal of Gastroenterology, vol. 12, no. 46, pp. 7413–7420, 2006. View at Scopus
  48. M. D. Wheeler, H. Kono, M. Yin et al., “The role of Kupffer cell oxidant production in early ethanol-induced liver disease,” Free Radical Biology and Medicine, vol. 31, no. 12, pp. 1544–1549, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Y. Li, X. Gu, W. H. Zhang, S. Jia, and Y. Zhou, “GdCl3 abates hepatic ischemia-reperfusion injury by inhibiting apoptosis in rats,” Hepatobiliary and Pancreatic Diseases International, vol. 8, no. 5, pp. 518–523, 2009. View at Scopus
  50. D. Henrich, M. Lehnert, C. Herzog et al., “Differential effects of GdCl3 or MDP treatment on rat liver microcirculation and gene expression in the hepatic non-parenchymal cell fraction in LPS shock,” Microcirculation, vol. 15, no. 5, pp. 427–439, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. E. Sturm, R. Havinga, J. F. W. Baller et al., “Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats,” Journal of Hepatology, vol. 42, no. 1, pp. 102–109, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. S. S. Du, M. Qiang, Z. C. Zeng et al., “Inactivation of Kupffer cells by gadolinium chloride protects murine liver from radiation-induced apoptosis,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 4, pp. 1225–1234, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. W. Huang, A. Metlakunta, N. Dedousis et al., “Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance,” Diabetes, vol. 59, no. 2, pp. 347–357, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. P. Neafsey, G. Ginsberg, D. Hattis, and B. Sonawane, “Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): population distribution of CYP2D6 activity,” Journal of Toxicology and Environmental Health Part B, vol. 12, no. 5-6, pp. 334–361, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus